Day Zero Diagnostics News Today

14 Nov 2023 OXFORD, England and BOSTON - November 14, 2023 - Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing...

Day Zero Diagnostics and Oxford Nanopore today announced a collaboration to develop a solution for diagnosing bloodstream infections.

/PRNewswire/ -- As Day Zero Diagnostics Inc. (DZD) unveils its latest innovations at the 2023 ID Week conference, highlighting AI-driven solutions to combat...

/PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Day Zero Diagnostics seeks to harness whole-genome sequencing and AI in the fight against antibiotic-resistant infections.

/PRNewswire/ -- Day Zero Diagnostics (DZD) Inc., a pioneer in infectious disease diagnostics, has received a Phase I Small Business Innovation Research (SBIR)...

The Boston firm will develop a sequencing-based safety and efficacy assay for fecal microbiota transplants called epiXact FMT.

/PRNewswire/ -- Day Zero Diagnostics Inc., an infectious disease diagnostics company utilizing genome sequencing and machine learning to combat the rise of...

Day Zero Diagnostics announced that it received an $8.2 million award in optional stage funding from CARB-X.